Clinical Trial Update: Validation of Molecular Diagnostic Thecnologies for Lung Cancer Patients.

View source ↗

Summary

A completed clinical trial evaluating molecular diagnostic technologies for lung cancer patients; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Neoplasms

Snippet

Sponsor: Pfizer | Conditions: Lung Neoplasms | Status: COMPLETED | Results posted: 2019-11-08